Beiersdorf, DE0005200000

Goldman Sachs cuts target for Beiersdorf stock from EUR 82.00 to EUR 73.00

Published on 10/21/2026 at 10:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half revenue fell 4.50 percent to EUR 4.95 billion. Beiersdorf stock costs EUR 81.65 on October 21, 2026, below its Xetra close.

Analyst pressure and recovery dates

Goldman Sachs changed its rating from Neutral to Sell and cut its target from EUR 82.00 to EUR 73.00 on October 6, 2026.
First-half 2026 revenue was EUR 4.95 billion, down 4.50 percent year over year.
Beiersdorf stock trades at EUR 81.65 at 10:17 a.m. CEST at Lang & Schwarz on October 21, 2026, 0.84 percent below the Xetra close of October 20, 2026.
Beiersdorf expects third-quarter 2026 results on October 27, 2026.

Aquarell-Illustration der Hamburger Speicherstadt mit Kanal-Reflexionen bei Abendlicht — Expressives Aquarell der Hamburger Speicherstadt bei Abenddämmerung: Backsteinlager spiegeln sich im Kanal, violett-bernsteinfarbene Wäschen, sichtbare Pinselstriche, Illustration mit AI erstellt.

Beiersdorf (ISIN DE0005200000) was trading at EUR 81.65 at Lang & Schwarz on October 21, 2026, at 10:17 a.m. CEST, down 0.84 percent versus the Xetra close of October 20, 2026 at EUR 82.34. The main company catalyst remains Goldman Sachs' October 6 decision to cut its rating and price target as NIVEA weakness weighs on the outlook.

According to Admirals, Goldman Sachs moved Beiersdorf from Neutral to Sell and reduced its target from EUR 82.00 to EUR 73.00 on October 6, 2026. The same source lists DZ Bank's EUR 74.00 fair value from October 1, 2026, showing how quickly the analyst range has shifted toward the current share price.

Why NIVEA matters for earnings

Beiersdorf's first-half 2026 revenue fell 4.50 percent year over year to EUR 4.95 billion, while net income was EUR 551.00 million, according to Simply Wall St. Earnings per share reached EUR 2.52 in the first half, compared with EUR 2.47 in the first half of 2025. The figures put the burden of recovery squarely on the core brand.

NIVEA organic sales fell 6.80 percent in the first half of 2026, while Derma revenue grew 7.80 percent to EUR 837.00 million, according to Admirals. Beiersdorf's investor-relations page says the company adjusted its full-year outlook and approved an 18-month NIVEA turnaround plan on August 3, 2026. The revised guidance calls for a low single-digit organic sales decline and a group EBIT margin excluding special factors of at least 11.80 percent.

Three dates shaped the stock

On March 2, 2026, Beiersdorf announced a buyback of up to EUR 750.00 million and initially expected flat to slightly growing organic sales. On August 3, 2026, it cut the outlook to a low single-digit organic sales decline and launched the NIVEA plan. On October 6, 2026, Goldman Sachs cut its target from EUR 82.00 to EUR 73.00, according to Admirals.

What comes next for investors?

Beiersdorf is scheduled to publish its third-quarter 2026 statement on October 27, 2026, according to Admirals. The release will offer the next quantified test of NIVEA's sales trend, Derma's growth and the 11.80 percent margin floor. A second date in the company's investor-relations calendar is the full-year 2026 results publication on March 4, 2027, as listed by TradingView.

Stock remains below the analyst range

The current euro quote is below the EUR 95.00 high among the targets listed by Admirals and above the EUR 68.00 low. That spread captures the unresolved balance between Derma's growth and the execution risk of the NIVEA reset.

Beiersdorf was trading at EUR 81.65 at Lang & Schwarz on October 21, 2026, at 10:17 a.m. CEST, 0.84 percent below the Xetra close of October 20, 2026 at EUR 82.34. The further course of trading is shown by the continuously updated real-time quote of Beiersdorf stock.